Epidemiological Assessment of NAFLD and Efficacy Evaluation of Nutritional and Exercise Intervention for NASH

Epidemiological Assessment of NAFLD and Efficacy Evaluation of Nutritional and Exercise Intervention for NASH - Epidemiology of NAFLD and non-pharmacological intervention for NASH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006368

Enrollment

Registered

2011-09-20

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcohol steatohepatitis

Interventions

If a case desired, non-pharmaceutical intervention is planned in the first 30 cases, which showed an abnormal study in one or more of liver stiffness, rigidity of carotid artery or serum fibrosis mark

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. No medical history in terms of chronic liver damage. 2. All of AST, ALT and GTP show abnormal values. 3. None of positive reaction for HBsAg, anti-HCV, AMA or ANA. 4. It is possible to be followed for a year. 5. A written informed consent from a patient himself/herself.

Exclusion criteria

Exclusion criteria: For the people to start an exercise training 1. A pulse oximeter revealed oxygen saturation less than 95% at rest. 2. Abnormality in a 12-lead electrocardiogram at rest. 3. A doctor judged to be an improper case for this study.

Design outcomes

Primary

Measure	Time frame
A year after the first evaluation	—

Countries

Japan

Contacts

Public ContactKenya Kamimura

Niigata University Graduate School of Medical and Dental Sciences Division of Gastroenterology & Hepatology

tspitt@med.niigta-u.ac.jp025-227-2207

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026